VentureMed Group Announces Bruce Fiedler as Chief Financial Officer
VentureMed Group, a distinguished innovator in the medical device industry, has recently made a strategic move by appointing Bruce Fiedler as the new Chief Financial Officer (CFO). This decision reinforces the company's dedication to enhancing its financial operations and supporting its growth in providing advanced vascular solutions for medical professionals and patients.
Bruce Fiedler's Impressive Background
Fiedler comes to VentureMed Group with a wealth of experience, previously holding significant roles at Boston Scientific. As Vice President, Finance & Global Controller for the Neuromodulation Division, he showcased his ability to manage financial planning and controls effectively for a major global business unit. His extensive track record and leadership in the healthcare finance sector position him as an asset to the company's future endeavors.
Driving Financial Excellence
In his role as CFO, Fiedler will be at the forefront of VentureMed Group's financial strategies, overseeing critical areas such as strategic planning, financial reporting, capital allocation, and investor relations. His proven ability to drive performance in complex and high-growth environments will be crucial as the company aims to enhance its operational capabilities.
Company Growth and Innovation Focus
VentureMed Group is dedicated to developing technologies that cater to the treatment of arteriovenous fistulas, grafts, and peripheral vascular diseases. With Fiedler's leadership, the company is poised to take significant strides toward achieving its goals of delivering transformative interventional vascular solutions. The management is focused on leveraging innovative approaches to address unmet clinical needs in this field.
Leadership Statements
Denis Harrington, President and CEO, expressed enthusiasm about Fiedler's appointment, remarking, "We are pleased to welcome Bruce to the VentureMed Group leadership team. His extensive financial expertise and experience in scaling operations will be invaluable as we embark on our next phase of growth." This sentiment underscores the importance of financial leadership in helping realize the company's strategic vision.
Commitment to Patient Care
Fiedler shared his excitement about joining VentureMed Group at this pivotal moment, stating, "The company's mission to address unmet clinical needs through innovative vascular solutions is compelling, and I look forward to working with the team to drive growth and meaningful impact for patients and physicians." His promise to contribute to enhancing patient care aligns perfectly with the company's core values.
Understanding VentureMed Group
VentureMed Group, Inc. stands as a pioneering medical device company based in Minnesota, focused on providing endovascular solutions for arteriovenous access and peripheral vascular disease interventions. Among its flagship technologies, the FLEX Vessel Prep™ System is recognized for its innovative approach to enhancing vessel preparation. This device, cleared by the FDA and approved by CE Mark, implements the proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology, setting a new standard in the industry.
Future of VentureMed Group
As Bruce Fiedler steps into this crucial role, the expectations are high for VentureMed Group to not only meet but exceed industry standards through financial resilience and operational excellence. With a commitment to creating value for patients and healthcare providers alike, the team anticipates a future filled with growth and impactful solutions.
Frequently Asked Questions
Who has been appointed as the new CFO of VentureMed Group?
Bruce Fiedler has been appointed as the new Chief Financial Officer of VentureMed Group.
What experience does Bruce Fiedler bring to his new role?
Fiedler has extensive experience in finance, previously serving as Vice President, Finance & Global Controller at Boston Scientific, where he managed financial planning for a global division.
What is the primary focus of VentureMed Group?
VentureMed Group specializes in developing medical devices aimed at vessel preparation and access management for treating vascular conditions, including arteriovenous fistulas and peripheral vascular diseases.
How will Fiedler's role impact VentureMed Group?
Fiedler's expertise in financial operations will support the company's strategic growth initiatives and enhance its ability to deliver innovative medical solutions.
What technology does VentureMed Group offer?
The company offers the FLEX Vessel Prep™ System, which utilizes proprietary technology to provide efficient vessel preparation for vascular interventions.
